PhD Cluster

Chemical nanomaterials for guided surgery in cancer

Enhancing cancer detection and enabling precision surgical intervention to reduce recurrence of the disease

The Challenge

Colorectal cancer is the second biggest cause of cancer deaths in the UK, with over 100 new patients diagnosed per day.

Progress with improving survival has been slow, whilst the disease burden has been increasing with the ageing population. More sophisticated methods of screening, diagnosis, treatment, and surveillance are required to address this major unmet clinical need. 

The Approach

We aim to develop a multimodal nanoparticle system targeted to rapidly growing and invasive colorectal cancer cells.

It will enhance disease detection and enable precision surgical intervention that reduces recurrence of the disease. It draws on successful interdisciplinary collaborations to develop organic nanoparticles for clinical applications. 



This cluster is part of a new UK wide research network in the area of clinical translation of nanoparticles and the exploitation of novel bio-targeting methodology to deliver a revolution in cancer diagnosis and treatment. 


microscopes in a lab
pet-lab (1)

The Impact

Refinement of surgical interventions in cancer to optimise margin resection in aggressive cancers and liver metastases could improve outcomes in up to a third of patients. There is potential to increase colorectal cancer patient survival in a disease affecting ~ 43,000 UK citizens per year. 



Accelerating a net zero future. Improving health outcomes. Promoting justice and fairness for all. Living with water. Enhancing heritage and creative industries.

Our research impacts the world.

And you can be part of it.

Join our vibrant research community and help find solutions to some of the biggest challenges facing the world today.